๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses

โœ Scribed by Lee, J.-M.; Hays, J. L.; Annunziata, C. M.; Noonan, A. M.; Minasian, L.; Zujewski, J. A.; Yu, M.; Gordon, N.; Ji, J.; Sissung, T. M.; Figg, W. D.; Azad, N.; Wood, B. J.; Doroshow, J.; Kohn, E. C.

Book ID
125530898
Publisher
Oxford University Press
Year
2014
Tongue
English
Weight
920 KB
Volume
106
Category
Article
ISSN
0027-8874

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Germline mutations of BRCA1 and BRCA2 in
Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families
โœ Hio Chung Kang; Il-Jin Kim; Jae-Hyun Park; Hyuk-Jun Kwon; Yong-Jin Won; Seung Ch ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 140 KB ๐Ÿ‘ 2 views

Germline mutations in the BRCA1 and BRCA2 genes are responsible for the predisposition and development of familial breast and/or ovarian cancer. Most mutations of BRCA1 and BRCA2 associated with breast and/or ovarian cancer result in truncated proteins. To investigate the presence of BRCA1 and BRCA2

BRCA1 and BRCA2 mutations in women with
BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic
โœ Lenka Foretova; Eva Machackova; Marie Navratilova; Hana Pavlu; Marcela Hruba; Mi ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 45 KB ๐Ÿ‘ 2 views

Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast and ovarian cancer. The complete coding sequence analysis of both genes was carried out in 197 breast/ovarian cancer patients from high-risk families and 53 patients with sporadic breast/ovarian cancer. In summary, 59 mu